106
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

MiR-17-5p inhibits cerebral hypoxia/reoxygenationinjury by targeting PTEN through regulation of PI3K/AKT/mTOR signaling pathway

, , &
Pages 192-200 | Received 28 Sep 2019, Accepted 20 Jul 2020, Published online: 17 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xiaoli Ren, Zhiyun Wang & Congfang Guo. (2021) MiR-195-5p Ameliorates Cerebral Ischemia-Reperfusion Injury by Regulating the PTEN-AKT Signaling Pathway. Neuropsychiatric Disease and Treatment 17, pages 1231-1242.
Read now

Articles from other publishers (5)

Ting Zheng, Taotao Jiang, Hongxiang Ma, Yanping Zhu & Manxia Wang. (2024) Targeting PI3K/Akt in Cerebral Ischemia Reperfusion Injury Alleviation: From Signaling Networks to Targeted Therapy. Molecular Neurobiology.
Crossref
Qunwen Pan, Yan Wang, Jinhua Liu, Xiaojuan Jin, Zhi Xiang, Suqing Li, Yumeng Shi, Yanfang Chen, Wangtao Zhong & Xiaotang Ma. (2023) MiR-17-5p Mediates the Effects of ACE2-Enriched Endothelial Progenitor Cell-Derived Exosomes on Ameliorating Cerebral Ischemic Injury in Aged Mice. Molecular Neurobiology 60:6, pages 3534-3552.
Crossref
Hui Kang, Hui Yu, Ling Zeng, Hao Ma & Ge Cao. (2022) LncRNA Rian reduces cardiomyocyte pyroptosis and alleviates myocardial ischemia–reperfusion injury by regulating by the miR-17-5p/CCND1 axis. Hypertension Research 45:6, pages 976-989.
Crossref
Xiang Ren, Ying-Xia Jing, Zhi-Wen Zhou & Jian-Wen Yang. (2022) Knockdown of circRNA-Memo1 Reduces Hypoxia/Reoxygenation Injury in Human Brain Endothelial Cells Through miRNA-17-5p/SOS1 Axis. Molecular Neurobiology 59:4, pages 2085-2097.
Crossref
Xiaohuan Xia, Yi Wang & Jialin C. Zheng. (2020) The microRNA-17 ~ 92 Family as a Key Regulator of Neurogenesis and Potential Regenerative Therapeutics of Neurological Disorders. Stem Cell Reviews and Reports 18:2, pages 401-411.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.